Pharmaceuticals
Sun Pharma chairman Israel Makov to retire on 29 August
08 Aug 2022
Makov has played a significant role in Sun Pharma’s transformation from a $1.7 billion organisation focusing on India and the US into the world's fourth largest specialty generic pharmaceutical company operating across 100+ markets with a turnover of over $5 billion